I was not shocked by the news of N706BL passing its
I was not shocked by the news of N706BL passing its inspections either.
All along I was led to believe the plane was in great shape. Passing its inspections surprised me as much as a straight A student getting another 94 on his exam. Happy, yes. Surprised, No.
The part that did surprise me....if it is true.....is that the next plane into the hangar is going to have its interior gutted and placed into N706BL. That I didn't know....and that surprises and pleases me at the same time.
As for the reassembly of N706BL taking another 2 weeks, that too falls pretty much in line with my belief that May is going to be a very interesting month.
What I REALLY would like to hear about is the finalizing of the pilots and crew training. That is the part that I am "up in the air about" (so to speak), and that kind of information would shock and please me way beyond any information about the plane.....................
Baltia Air Lines Inc (BLTA) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...
Continue Reading
Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...
Continue Reading
Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...
Continue Reading
Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...
Continue Reading
PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...
Continue Reading